FIBRINOGEN AND ITS COMPLEX PLASMA CONTENT UNDER ISCEMIC STROKE WITH OR WITHOUT DIABETES MELLITUS


  • O.O. Kravchenko The Educational and Scientific Centre “Institute of Biology and Medicine” of Taras Shevchenko National University of Kyiv, Ukraine
Keywords: stroke; diabetes mellitus, type 2; blood coagulation factors

Abstract

FIBRINOGEN AND ITS COMPLEX PLASMA CONTENT UNDER ISCEMIC STROKE WITH OR WITHOUT DIABETES MELLITUS

References

1. Abdullah WZ, Moufak SK, Yusof Z, Mohamad MS Kamarul IM.Shortened activated partial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event. Translational Research: the journal of laboratory and clinical medicine. 2010; 155:315-9.



2. Koga S. A novel molecular marker for thrombus formation and life prognosis-clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF). RinshoByori. 2004;52: 355-61.



3. Fayeza Karim, Qazi Shamima Akter, Shamima Jahan, Afruza Khanom, Samira Haque, Tania Yeasmin, et al. Coagulation Impairment in Type 2 Diabetes Mellitus. J Bangladesh Soc Physiol. 2015, 10: 26-29.



4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539– 553.



5. A.V. Tokar, E.M. Makogonenko, T.M. Platonova Modern methods of intravenous micro-coagulation laboratory diagnostic (guidelines), Kyiv.: Maccom; 1994.



6. N. V. Zaichko, T. M. Chernyshenko, T. M. Platonova, G. L. Volkov Іnfluence of soluble fibrin on the blood coagulation process and platelets aggregation. The UkrBiochem.J. 2006; 78:118-23.
Published
2018-03-24
How to Cite
Kravchenko, O. (2018). FIBRINOGEN AND ITS COMPLEX PLASMA CONTENT UNDER ISCEMIC STROKE WITH OR WITHOUT DIABETES MELLITUS. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(1), 28-31. https://doi.org/10.29256/v.02.01.2018.escbm11
Section
Selected abstracts